Mitsuru Kakihana

This inventor holds 7 USPTO granted patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 1999-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuru Kakihana. Retrieved from https://idiyas.com/inventor/mitsuru-kakihana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 57.1

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 86(Granted Patents)

Location History:

Hyogo, JP (2006)
Kobe, JP (1999 - 2007)

Company Filing History:

6 out of 1,858

Takeda Chemical Industries, Inc.

patents

1 out of 1,226

Takeda Pharmaceutical Company Limited

patents

Years Active: 1999-2007

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7256204 - Amine compounds, their production and use (2007-08-14),

2. 7008950 - Benzofurans as suppressors of neurodegeneration (2006-03-07),

3. 6930104 - Heterocyclic derivatives (2005-08-16),

4. 6613805 - Amine compounds, their production and use (2003-09-02),

5. 6586475 - &bgr;-amyloid protein production/secretion inhibitors (2003-07-01),

6. 6310107 - Amine compounds, their production and use as amyloid-&bgr; production inhibitors (2001-10-30),

7. 5965568 - Composition for inhibiting production or secretion of amyloid .beta. (1999-10-12),

Title: Mitsuru Kakihana: Innovator in Neurodegenerative Disease Research

Introduction

Mitsuru Kakihana is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative diseases. With a total of 7 patents to his name, Kakihana's work has garnered attention in the scientific community.

Latest Patents

Kakihana's latest patents include innovative compounds that have shown potential in inhibiting amyloid-β protein production and secretion. One notable patent describes a compound with a complex formula that includes aromatic ring assemblies and various functional groups. This compound is useful as a pharmaceutical composition for preventing and treating neurodegenerative diseases. Another patent focuses on benzofurans, which serve as agents for suppressing neurodegeneration, showcasing Kakihana's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Mitsuru Kakihana has worked with esteemed organizations such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research and drug development.

Collaborations

Kakihana has collaborated with notable colleagues, including Kaneyoshi Kato and Jun Terauchi. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

Mitsuru Kakihana's contributions to the pharmaceutical industry, particularly in the realm of neurodegenerative disease research, highlight his role as an influential inventor. His innovative patents and collaborations reflect a dedication to improving health outcomes through scientific advancement.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]